Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignancies.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
22 09 2021
Historique:
received: 16 03 2020
accepted: 03 09 2021
entrez: 23 9 2021
pubmed: 24 9 2021
medline: 21 10 2021
Statut: epublish

Résumé

Cancer cells depend on actin cytoskeleton rearrangement to carry out hallmark malignant functions including activation, proliferation, migration and invasiveness. Wiskott-Aldrich Syndrome protein (WASp) is an actin nucleation-promoting factor and is a key regulator of actin polymerization in hematopoietic cells. The involvement of WASp in malignancies is incompletely understood. Since WASp is exclusively expressed in hematopoietic cells, we performed in silico screening to identify small molecule compounds (SMCs) that bind WASp and promote its degradation. We describe here one such identified molecule; this WASp-targeting SMC inhibits key WASp-dependent actin processes in several types of hematopoietic malignancies in vitro and in vivo without affecting naïve healthy cells. This small molecule demonstrates limited toxicity and immunogenic effects, and thus, might serve as an effective strategy to treat specific hematopoietic malignancies in a safe and precisely targeted manner.

Identifiants

pubmed: 34552085
doi: 10.1038/s41467-021-25842-7
pii: 10.1038/s41467-021-25842-7
pmc: PMC8458504
doi:

Substances chimiques

Actins 0
Antineoplastic Agents 0
Cytoskeletal Proteins 0
Integrins 0
Intracellular Signaling Peptides and Proteins 0
Small Molecule Libraries 0
WAS protein, human 0
WIPF1 protein, human 0
Wiskott-Aldrich Syndrome Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5581

Informations de copyright

© 2021. The Author(s).

Références

Sci Signal. 2014 Jun 24;7(331):ra60
pubmed: 24962707
J Cell Biol. 2015 Feb 16;208(4):475-91
pubmed: 25666810
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
Sci Signal. 2016 May 24;9(429):ra54
pubmed: 27221712
Cell Rep. 2018 Jan 23;22(4):979-991
pubmed: 29386139
Methods. 2017 Feb 15;115:80-90
pubmed: 27713081
Int Rev Cell Mol Biol. 2020;356:131-196
pubmed: 33066873
Cell. 2017 Feb 9;168(4):707-723
pubmed: 28187290
J Immunol. 2017 Jan 1;198(1):40-46
pubmed: 27994167
Blood. 2000 May 1;95(9):2943-6
pubmed: 10779443
J Chem Inf Model. 2005 Mar-Apr;45(2):422-30
pubmed: 15807508
J Clin Invest. 1996 Jun 1;97(11):2627-34
pubmed: 8647957
Ann Oncol. 1999 Dec;10(12):1419-32
pubmed: 10643532
PLoS Comput Biol. 2010 Nov 04;6(11):e1000976
pubmed: 21079673
Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4379-83
pubmed: 15070726
Ann N Y Acad Sci. 2013 May;1285:26-43
pubmed: 23527602
Mol Cell Biol. 2012 Aug;32(15):3153-63
pubmed: 22665495
Immunology. 2012 Oct;137(2):183-96
pubmed: 22804504
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Cancer Sci. 2005 Jul;96(7):379-86
pubmed: 16053508
J Immunol. 1999 Apr 15;162(8):5019-24
pubmed: 10202051
PLoS One. 2020 Jul 28;15(7):e0232565
pubmed: 32722676
Blood. 2010 Apr 8;115(14):2818-26
pubmed: 20130240
J Med Chem. 1995 Jun 9;38(12):2080-90
pubmed: 7783139
N Engl J Med. 2014 Oct 16;371(16):1507-17
pubmed: 25317870
Science. 2003 Sep 19;301(5640):1720-5
pubmed: 14500982
PLoS One. 2012;7(1):e30033
pubmed: 22279563
Blood Adv. 2017 Dec 12;1(26):2643-2654
pubmed: 29296917
Mol Cell Biol. 2011 Jul;31(13):2653-66
pubmed: 21536650
Microsc Res Tech. 1999 Oct 15;47(2):107-13
pubmed: 10523789
N Engl J Med. 2012 Jun 28;366(26):2443-54
pubmed: 22658127
Biochim Biophys Acta. 2007 May;1773(5):642-52
pubmed: 16926057
Eur J Cancer. 2016 Feb;54:139-148
pubmed: 26765102
J Leukoc Biol. 2005 Jun;77(6):993-8
pubmed: 15774550
Blood. 2007 Dec 15;110(13):4278-84
pubmed: 17673604
EMBO J. 2018 Mar 1;37(5):
pubmed: 29449322
J Biol Chem. 2006 Feb 10;281(6):3513-20
pubmed: 16293614
Semin Hematol. 2009 Jul;46(3):289-312
pubmed: 19549581
Leukemia. 2021 Mar;35(3):777-786
pubmed: 32601377
Oncogene. 2010 Oct 14;29(41):5545-55
pubmed: 20697348
Blood. 2009 Jun 18;113(25):6288-95
pubmed: 19351959
Neoplasia. 2017 Aug;19(8):649-658
pubmed: 28732212
Oncogene. 2014 Dec 11;33(50):5655-65
pubmed: 24469030
Cell Motil Cytoskeleton. 2009 Jun;66(6):303-16
pubmed: 19373774
Bioinformatics. 2011 Jul 1;27(13):1814-21
pubmed: 21586518
CA Cancer J Clin. 2005 Nov-Dec;55(6):368-76
pubmed: 16282281
Blood. 2012 Mar 15;119(11):2590-4
pubmed: 22279054
Nat Immunol. 2005 Jan;6(1):80-9
pubmed: 15558067
Immunity. 2006 Aug;25(2):285-95
pubmed: 16901726
J Exp Med. 2008 Jan 21;205(1):195-205
pubmed: 18195072
Sci Signal. 2012 Apr 24;5(221):rs3
pubmed: 22534133
Blood. 1997 Oct 15;90(8):3089-97
pubmed: 9376590
Oncogene. 2005 Feb 17;24(8):1309-19
pubmed: 15608687
Mol Ther Oncolytics. 2016 Apr 20;3:16011
pubmed: 27626062
Nat Immunol. 2008 Mar;9(3):254-62
pubmed: 18246070
Farmaco Sci. 1979 Mar;34(3):248-76
pubmed: 43264
Annu Rev Immunol. 2009;27:339-62
pubmed: 19302044
Cells. 2019 Jun 26;8(7):
pubmed: 31248017
Clin Exp Metastasis. 2009;26(4):273-87
pubmed: 18498004
Springer Semin Immunopathol. 2004 Nov;26(1-2):71-94
pubmed: 15549304
Cancer Sci. 2010 Oct;101(10):2093-104
pubmed: 20707804
Nurs Res. 2009 Mar-Apr;58(2):105-14
pubmed: 19289931
Science. 1992 Aug 21;257(5073):1078-82
pubmed: 1509259
Int J Mol Sci. 2012;13(6):7629-47
pubmed: 22837718
Nature. 2005 Aug 4;436(7051):660-5
pubmed: 16079837
Cancer. 1989 Feb 1;63(3):604-12
pubmed: 2912536
N Engl J Med. 2017 Dec 28;377(26):2545-2554
pubmed: 29226764
Exp Hematol. 2005 Apr;33(4):443-51
pubmed: 15781335
Nephrol Dial Transplant. 2017 Jun 1;32(6):936-942
pubmed: 28025384
Sci Rep. 2015 Oct 14;5:15031
pubmed: 26463123
Immunol Rev. 2013 Nov;256(1):282-99
pubmed: 24117828
J Cell Biol. 2008 Mar 24;180(6):1245-60
pubmed: 18362183
Nat Rev Cancer. 2016 May 25;16(6):387-98
pubmed: 27220482
EMBO J. 2010 Jul 21;29(14):2315-28
pubmed: 20562827
Int Immunol. 2007 Feb;19(2):185-92
pubmed: 17205972
Eur J Biochem. 1977 Nov 1;80(2):319-24
pubmed: 923582
Cancer Metastasis Rev. 2009 Jun;28(1-2):5-14
pubmed: 19153674
Blood. 2005 Feb 1;105(3):1144-52
pubmed: 15383456
J Vis Exp. 2013 Aug 15;(78):
pubmed: 23979559
Oncogene. 2017 Apr;36(15):2085-2094
pubmed: 27694894
Cell. 2017 Jun 29;170(1):17-33
pubmed: 28666118
J Immunol. 1992 Feb 15;148(4):1080-5
pubmed: 1371129
Blood. 2012 Apr 26;119(17):3966-74
pubmed: 22411869
J Biomol Struct Dyn. 2019 Oct;37(17):4644-4650
pubmed: 30526403
J Clin Med Res. 2019 Apr;11(4):225-236
pubmed: 30937112
J Immunol. 1993 Oct 15;151(8):4383-90
pubmed: 8409409
Chem Biol Interact. 2001 Jun 1;135-136:653-64
pubmed: 11397419
J Immunol. 2009 Jun 15;182(12):7370-80
pubmed: 19494259
J Mol Cell Immunol. 1990;4(6):317-25
pubmed: 2150484
J Clin Oncol. 1998 Jun;16(6):2065-9
pubmed: 9626205
Blood. 1996 May 15;87(10):4340-7
pubmed: 8639794
Sci Rep. 2017 Mar 23;7:44863
pubmed: 28332566
Blood. 2004 Jan 15;103(2):456-64
pubmed: 12969986
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Immunol. 2013 Apr 1;190(7):3661-9
pubmed: 23455509
Cancer Res. 1989 Sep 1;49(17):4682-9
pubmed: 2547513
Immunobiology. 2009;214(9-10):778-90
pubmed: 19628299
PLoS One. 2013 Sep 19;8(9):e75436
pubmed: 24069415
Nat Rev Cancer. 2011 Mar;11(3):177-87
pubmed: 21326322
J Leukoc Biol. 2014 Nov;96(5):713-27
pubmed: 25210148
Adv Clin Exp Med. 2018 Jul;27(7):987-999
pubmed: 29893517
J Exp Med. 1999 Nov 1;190(9):1329-42
pubmed: 10544204
J Biol Chem. 2014 Dec 12;289(50):34503-19
pubmed: 25342748
J Biol Chem. 2007 Mar 16;282(11):8446-53
pubmed: 17229736
N Engl J Med. 2015 Jan 22;372(4):311-9
pubmed: 25482239
Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1409-E1418
pubmed: 29386393
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W363-7
pubmed: 15980490
J Cell Sci. 2003 Aug 1;116(Pt 15):3123-33
pubmed: 12799414

Auteurs

Guy Biber (G)

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel.

Aviad Ben-Shmuel (A)

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel.

Elad Noy (E)

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel.

Noah Joseph (N)

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel.

Abhishek Puthenveetil (A)

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel.

Neria Reiss (N)

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel.

Omer Levy (O)

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel.

Itay Lazar (I)

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel.

Ariel Feiglin (A)

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel.

Yanay Ofran (Y)

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel.

Meirav Kedmi (M)

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel.
Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Abraham Avigdor (A)

Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Sophia Fried (S)

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel.

Mira Barda-Saad (M)

The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, 5290002, Israel. Mira.Barda-Saad@biu.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH